Integration of DNA Methylome and Transcriptome Analysis to Identify Novel Epigenetic Targets in the Acute Kidney Injury–Chronic Kidney Disease Transition
Biomolecules · 2025
DOI: 10.3390/biom15040498 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Xumin Zheng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Nephrology Institute of the Chinese People's Liberation Army, State K…. Hauptthemen laut MEDLINE: Acute Kidney Injury, Renal Insufficiency, Chronic, DNA Methylation, Epigenesis, Genetic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Municipal Natural Science Foundation, Natural Science Foundation of China.
Abstract (Originalsprache)
(1) Background: the epigenetic mechanisms underlying the progression from acute kidney injury (AKI) to chronic kidney disease (CKD) remain poorly understood; (2) Methods: to investigate this process, we conducted genome-wide DNA methylation sequencing to map the epigenetic changes during the AKI-CKD transition in a mouse model. By integrating DNA methylome and transcriptome analyses, we identified genes and signaling pathways regulated by DNA methylation throughout this progression; (3) Results: our analysis identified four candidate genes—Atp1a3, Ncf1, Lpl, and Slc27a2—that were regulated by DNA methylation and strongly correlated with kidney disease prognosis. Additionally, we found that the PPAR signaling pathways, among others, were implicated in this process. Treatment with DNA methyltransferase inhibitors mitigated fibrosis and improved lipid metabolism in the kidneys during AKI-CKD progression; (4) Conclusions: this study provides the first comprehensive epigenetic map of the AKI-CKD transition. Our findings offer new insights into the epigenetic regulation of kidney disease progression and highlight potential therapeutic targets to prevent the transition from AKI to CKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Nephrology Institute of the Chinese People's Liberation Army, State Key Laboratory of Kidney Diseases, National Clinical Research Center fo…
- School of Medicine, Nankai University, Tianjin 300071, China.
ORCID-Profile: Xinru Guo
Förderung
- National Natural Science Foundation of China
- Beijing Municipal Natural Science Foundation
- Natural Science Foundation of China
Zitieren
APA
Zheng, X., Guo, X., Chen, Y., Zhuang, K., Gong, N., Fu, Y., Liang, Y., Xu, Y., Wang, S., Wang, W., Chen, X., & Cai, G. (2025). Integration of DNA Methylome and Transcriptome Analysis to Identify Novel Epigenetic Targets in the Acute Kidney Injury–Chronic Kidney Disease Transition. Biomolecules. https://doi.org/10.3390/biom15040498
Vancouver
Zheng X, Guo X, Chen Y, Zhuang K, Gong N, Fu Y, et al. Integration of DNA Methylome and Transcriptome Analysis to Identify Novel Epigenetic Targets in the Acute Kidney Injury–Chronic Kidney Disease Transition. Biomolecules. 2025. doi:10.3390/biom15040498
BibTeX
@article{Zheng2025,
author = {Zheng, Xumin and Guo, Xinru and Chen, Yuhao and Zhuang, Kaiting and Gong, Na and Fu, Yifei and Liang, Yanjun and Xu, Yue and Wang, Siyang and Wang, Wenjuan and Chen, Xiangmei and Cai, Guangyan},
title = {Integration of DNA Methylome and Transcriptome Analysis to Identify Novel Epigenetic Targets in the Acute Kidney Injury–Chronic Kidney Disease Transition},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15040498}
}
EUVIMED